Skip to main content
. 2004 Apr 19;2004(2):CD002904. doi: 10.1002/14651858.CD002904.pub2

Stokes 1987.

Methods Generation of the allocation sequence: unclear (not reported). 
 Allocation concealment: 
 unclear (not reported). 
 Blinding: yes ‐ adequately blinded with identical placebo. 
 Follow‐up: Inadequate. Twelve weeks after treatment. The number or reasons for dropouts and withdrawals were not described.
Participants Patients with non‐A, non‐B chronic hepatitis based on clinical criteria, negative hepatitis‐B serology, and compatible liver histology.
Interventions Prednisone group: 
 all patients received 60 mg/day for two weeks followed by two weeks with 30 mg/day.
Placebo group: 
 all patients received identical placebo.
Outcomes ALT.
Notes Only abstract. 
 No information on health economics was provided.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear